Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

Collegium to Present Pediatric and Real-World Research Across ADHD Portfolio at AACAP and NEI Fall Congresses

October 21, 2026

Seven presentations include pediatric Phase 4 studies of AZSTARYS® (Serdexmethylphenidate/dexmethylphenidate) CII and real-world research of JORNAY PM® (Delayed-Release/Extended-Release...

Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life

Performance

52-Week Range 53.7% below 52-week high

23.50

21.4352W Low 50.7952W High

1 Week 1.4% below 1-week high

22.571W Low 23.841W High

Collegium Pharmaceutical, Inc. - Common Stock (COLL) traded between $21.43 and $50.79 over the past 52 weeks and last traded at $23.50, 53.7% below its 52-week high. Over the past week it ranged between $22.57 and $23.84.

Past 12 Months

+1.3%

+3.2%

-34.0%

-27.2%

-48.4%

-34.2%

1W +$0.31

1M +$0.72

3M -$12.09

6M -$8.78

YTD -$22.03

1Y -$12.21

COLL was -34.2% over the past year, -27.2% over six months, -48.4% year to date, +1.3% in the last week.

12 Months vs Market

COLL

-34.2%

DIA

+13.3%

SPY

+14.4%

QQQ

+16.3%

IWM

+13.7%

Over the past 12 months COLL returned -34.2% versus DIA (Dow) +13.3%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +16.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 0.00× 3-mo avg

Today 9 3-mo avg 790.0K

605.6K

728.1K

790.0K

618.9K

YTD

580.0K

567.8K

COLL most recently traded 9 shares against a 3-month average daily volume of 790.0K.

More News

October 06, 2026

Collegium Pharmaceutical (NASDAQ:COLL) Tumbles on Revenue Miss and Lowered Guidance ↗

August 06, 2026

Via Chartmill

3 Healthcare Stocks That Concern Us

September 30, 2026

3 Value Stocks That Fall Short

September 28, 2026

1 Oversold Stock Ready to Bounce Back and 2 We Find Risky

September 22, 2026

1 Cash-Producing Stock on Our Buy List and 2 That Underwhelm

September 21, 2026

Collegium to Participate in Upcoming Investor Conferences

September 08, 2026

Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Via The Motley Fool

Collegium Announces $50 Million Accelerated Share Repurchase Program

August 13, 2026

5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call

August 13, 2026

COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance

August 07, 2026

Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops

Collegium Pharmaceutical Q2 Earnings Call Highlights ↗

August 06, 2026

Via MarketBeat

August 06, 2026

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

August 06, 2026

Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

August 04, 2026

Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks

July 23, 2026

Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026

July 23, 2026

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston

July 20, 2026

1 Healthcare Stock with Competitive Advantages and 2 We Question

July 16, 2026

1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm

July 07, 2026

1 Mooning Stock to Own for Decades and 2 That Underwhelm

July 03, 2026

2 Profitable Stocks to Keep an Eye On and 1 We Brush Off

July 02, 2026

3 of Wall Street’s Favorite Stocks We Approach with Caution

June 19, 2026